Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
LSD
amphetamine Hallucinogen |
| gptkbp:CASNumber |
1539266-21-1
|
| gptkbp:chemicalFormula |
C13H18F3NO3
|
| gptkbp:discoveredBy |
gptkb:David_E._Nichols
|
| https://www.w3.org/2000/01/rdf-schema#label |
25TFM-NBOMe
|
| gptkbp:IUPACName |
2-(4-trifluoromethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
|
| gptkbp:legalStatus |
illegal in Hungary
illegal in Sweden |
| gptkbp:mechanismOfAction |
5-HT2A receptor agonist
|
| gptkbp:molecularWeight |
293.29 g/mol
|
| gptkbp:otherName |
2C-TFM-NBOMe
NBOMe-2C-TFM |
| gptkbp:relatedTo |
gptkb:2C-TFM
|
| gptkbp:routeOfAdministration |
oral
sublingual buccal |
| gptkbp:bfsParent |
gptkb:NBOMe_series
|
| gptkbp:bfsLayer |
7
|